Status:
RECRUITING
Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Lymphedema
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Lymphedema is a chronic disease that causes lymph to accumulate in the interstitial tissue. The lymphatic network is involved in the metabolism of lipids and lipoproteins, and this accumulation leads ...
Detailed Description
Lymphedema is a chronic disease that causes lymph to accumulate in the interstitial tissue. The lymphatic network is involved in the metabolism of lipids and lipoproteins, and this accumulation leads ...
Eligibility Criteria
Inclusion
- Patients over 18 years of age.
- Patient with primary or secondary lymphedema confirmed at consultation or in day hospital.
- Signature of informed consent.
- Person affiliated to or benefiting from a social security scheme
Exclusion
- Person refusing informed consent.
- Pregnant or breast-feeding women (urine pregnancy test performed in women of -childbearing age).
- Patients undergoing secondary cardiovascular prevention (MI, stroke, AOMI, etc.).
- Persons deprived of their liberty by judicial or administrative decision, persons under legal protection.
Key Trial Info
Start Date :
December 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 11 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05962827
Start Date
December 8 2023
End Date
August 11 2026
Last Update
December 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Nice
Nice, France, France, 06000
2
Centre antoine lacassagne
Nice, France, France, 06003